- OVERALL The principal aim of the UC Davis ADC (UCD ADC) is to measure trajectories of cognitive change and transition to dementia among a carefully studied and highly diverse subject cohort in order identify modifiable risk and protective factors with the ultimate goal of developing novel interventions to improve cognitive health and prevent dementia. This principal aim is accomplished through recruitment, maintenance and longitudinal follow up to autopsy of a cohort of subjects from both community and clinical referral sources that varies along the spectrum of cognitive ability, race/ethnicity, educational achievement, social economic status, spoken language and degrees of medical comorbidity. To accomplish this principal aim, the UCD ADC utilizes six highly integrated resource cores and a research education component to create a strong research infrastructure while emphasizing a highly collaborative environment to facilitate novel research efforts, education and training. In addition, UCD ADC encourages researcher diversity through the newly developed Latino Aging Research Resource Center (LARRC) a NIA Resource Center in Minority Aging Research (RCMAR) program. This highly diverse and predominantly cognitively normal cohort was developed to pursue four major scientific themes: 1) identify the earliest clinical and biological evidence of age-related dementing diseases, 2) identify and evaluate protective factors with emphasis on developing strategies to increase cerebral reserve or resistance to age-related degenerative diseases, 3) examination of the impact of mixed pathological processes on cognitive decline and conversion to dementia and 4) discovery and evaluation of biological markers of cognitive health or decline. In line with the pressing need to develop novel clinical therapeutics for AD, the UCD ADC also has begun to support investigator sponsored therapeutic studies. This work, performed in a highly collaborative and inclusive environment that fully utilizes the unique resources of the UC Davis environment and the skills of our collaborators, not only aims to advance new scientific knowledge, but also encourages new and innovative research, improved clinical diagnoses, training, patient and community education and superb data management and data sharing to leverage ongoing activities of the UCD ADC to the wider research and educational community. To obtain these objectives, the overall specific aims of the UCD ADC are to: Provide an environment and core resources to enhance cutting-edge research as well as encouraging extensive use of these resources by basic science, biomedical, behavioral, social and clinical investigators. Manage these resources ethically, responsibly and efficiently through a well-established and highly effective administrative structure that seeks to foster new and innovative areas of research and treatments. Provide investigators and research groups with a unique resource of well-characterized patients and control subjects through recruitment, retention and comprehensive assessment of a highly diverse cohort. Provide a rich training environment for students, fellows and junior faculty to acquire research skills and experience in interdisciplinary aging and dementia research as well as mentor new and diverse faculty members. Respond effectively to national needs related to AD and associated dementing disorders by timely submission of NACC reports, support of NACC data acquisition through MRI analyses and DNA submissions. Educate individuals across the knowledge spectrum from medical professionals to the lay public and share new scientific information developed at the UCD ADC with NIA stakeholders. Continue dementia advocacy in collaboration with the Alzheimer's Association at local, national and international levels, as well as supporting the NIA through service on various committees.

Public Health Relevance

- OVERALL The principal aim of the UC Davis ADC (UCD ADC) is to measure trajectories of cognitive change and transition to dementia among a carefully studied and highly diverse subject cohort in order identify modifiable risk and protective factors with the ultimate goal of developing novel interventions to improve cognitive health and prevent dementia. This principal aim is accomplished through recruitment, maintenance and longitudinal follow-up to autopsy of a cohort of subjects from both community and clinical referral sources that varies along the spectrum of cognitive ability, race/ethnicity, educational achievement, social economic status, spoken language and degrees of medical comorbidity. To accomplish this principal aim, the UCD ADC utilizes six highly integrated resource cores and a research education component to create a strong research infrastructure while emphasizing a highly collaborative environment to facilitate novel research efforts, education and training.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010129-27
Application #
9321085
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Silverberg, Nina B
Project Start
1997-07-15
Project End
2021-06-30
Budget Start
2017-08-15
Budget End
2018-06-30
Support Year
27
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of California Davis
Department
Neurology
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Chen, Yi-Je; Nguyen, Hai M; Maezawa, Izumi et al. (2018) Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke. Ann Clin Transl Neurol 5:147-161
Di Lucente, Jacopo; Nguyen, Hai M; Wulff, Heike et al. (2018) The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo. Glia 66:1881-1895
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
La Joie, Renaud; Ayakta, Nagehan; Seeley, William W et al. (2018) Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement :
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17

Showing the most recent 10 out of 1156 publications